The higher dependence of both naïve CD4 T cells and naïve ABC on PR signals, indicates that agonists that trigger downstream impacts of PR signals, need to be provided by vaccines that are designed to protect the aged against new threats such as new strains of influenza and emerging novel viruses such as SARS-CoV-2 as indicated in Figure 2. Here, CD4 is linked to influenza.